Sonodynamic Therapy for Glioblastoma: Clinical Trial Begins in Milan, Italy

A clinical trial investigating the safety and feasibility of using sonodynamic therapy (SDT) in patients with newly diagnosed glioblastomas (GBMs), a primary malignant brain tumor, has begun enrolling patients at the Fondazione IRCCS Neurologic Institute C.Besta in Milan, Italy.
The study is led by Francesco Prada MD, Neurosurgeon, Director of the Acoustic Neuroimaging and Therapy Laboratory at Fondazione IRCCS Istituto Neurologico Carlo Besta in Milan. Dr. Prada is also a former Focused Ultrasound Foundation fellow and serves as an advisor to the Foundation’s Brain Program. The Foundation is funding this clinical trial.
Read the Newsletter Article: www.fusfoundat...

[@jolespadavecchia5910]

Amazing! Congratulations

[@haroldoigreja790]

I intend to get an analyse .

[@reymosely9138]

Thanks a lot for this. use a service such as 'PromoSM'!!!